Back
Armata Pharmaceuticals, Inc. Stock Predictions
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
37
ARMP
Armata Pharmaceuticals, Inc.
Last Price:
$5.83
Seasonality Move:
17%
7 Day Trial
ALL ACCESS PASS
$
7
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiArmata Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Armata Pharmaceuticals, Inc. has on average historically risen by 7.2% based on the past 31 years of stock performance.
-
Armata Pharmaceuticals, Inc. has risen higher in 12 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 38.71%
-
Is Armata Pharmaceuticals, Inc. Stock Undervalued?The current Armata Pharmaceuticals, Inc. [ARMP] share price is $5.99. The Score for ARMP is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
ARMP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Armata Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Armata Pharmaceuticals, Inc. has on average historically risen by 7.2% based on the past 31 years of stock performance.
Armata Pharmaceuticals, Inc. Stock Rating
Sell
37
Armata Pharmaceuticals, Inc. (ARMP)
is a Sell
Is Armata Pharmaceuticals, Inc. overpriced?
-
Armata Pharmaceuticals, Inc. has risen higher in 12 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 38.71%
Armata Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
armatapharma.com
52-Week Data
52-Week High:
16.34
52-Week Low:
0.90
Prediction Charts
Market Cap:
217.6M
Price in USD:
5.99
Volume:
75.9K
Beta:
1.68
Technical Analysis
SMA50:
5.03
SMA100:
3.83
SMA200:
2.79
52-Wk Change:
179.91%
Stock Predictions
-
Is Armata Pharmaceuticals, Inc. stock public?Yes, Armata Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Armata Pharmaceuticals, Inc. stock quote today?The Armata Pharmaceuticals, Inc. stock price is 5.99 USD today.
-
How to buy Armata Pharmaceuticals, Inc. stock online?You can buy Armata Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-13 | 6.34 | 6.38 | 6.61 | 6.04 |
| Nov-14 | 6.38 | 7.32 | 7.32 | 6.00 |
| Nov-17 | 7.17 | 6.71 | 7.25 | 5.83 |
| Nov-18 | 6.58 | 6.88 | 7.20 | 6.53 |
| Nov-19 | 7.00 | 7.30 | 7.35 | 7.00 |
| Nov-20 | 7.37 | 7.15 | 7.44 | 6.52 |
| Nov-21 | 7.06 | 7.03 | 7.15 | 6.69 |
| Nov-24 | 7.01 | 6.86 | 7.15 | 6.82 |
| Nov-25 | 7.05 | 7.10 | 7.25 | 6.81 |
| Nov-26 | 7.26 | 7.22 | 7.40 | 7.10 |
| Nov-28 | 7.22 | 7.33 | 7.38 | 7.05 |
| Dec-1 | 7.05 | 6.77 | 7.25 | 6.62 |
| Dec-2 | 6.57 | 5.31 | 6.72 | 5.21 |
| Dec-3 | 5.34 | 5.99 | 5.99 | 5.34 |
Armata Pharmaceuticals, Inc. Earnings
Armata Pharmaceuticals, Inc. Earnings Report: Per Share Armata Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Armata Pharmaceuticals, Inc. Forecast Revenue Growth
Armata Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Armata Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.51 per share, and a decrease next year of $0.00 per share.
* Armata Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.